RNA interference (RNAi) has been used for selective degradation of an mRNA transcript or inhibiting its translation to a functional protein in various species. Here, we applied the RNAi approach to suppress the expression of the maternal transcript C-mos and embryonic transcripts Oct-4 in bovine oocytes and embryos respectively, using microinjection of sequence-specific double-stranded RNA (dsRNA). For this, 435 bp C-mos and 341 bp Oct-4 dsRNA were synthesized and microinjected into the cytoplasm of immature oocytes and zygotes respectively. In experiment 1, immature oocytes were categorized into three groups: those injected with C-mos dsRNA, RNase-free water and uninjected controls. In experiment 2, in vitro produced zygotes were categorized into three groups: those injected with Oct-4 dsRNA, RNase-free water and uninjected controls. The developmental phenotypes, the level of mRNA and protein expression were investigated after treatment in both experiments. Microinjection of C-mos dsRNA has resulted in 70% reduction of C-mos transcript after maturation compared to the water-injected and uninjected controls (P!0.01). Microinjection of zygotes with Oct-4 dsRNA has resulted in 72% reduction in transcript abundance at the blastocyst stage compared to the uninjected control zygotes (P!0.01). Moreover, a significant reduction in the number of inner cell mass (ICM) cells was observed in Oct-4 dsRNA-injected embryos compared to the other groups. From oocytes injected with C-mos dsRNA, 60% showed the extrusion of the first polar body compared to 50% in water-injected and 44% in uninjected controls. Moreover, only oocytes injected with C-mos dsRNA showed spontaneous activation. In conclusion, our results demonstrated that sequence-specific dsRNA can be used to knockdown maternal or embryonic transcripts in bovine embryogenesis.
Introduction
Presently, the genomes of various species including the bovine are largely sequenced. Moreover, several studies have been carried out during the last decade to investigate the expression patterns of genes in bovine embryogenesis in response to the various culture and treatment conditions (Rizos et al. 2002 , Lonergan et al. 2003a , 2003b , Tesfaye et al. 2004 , El-Halawany et al. 2005 . Despite this fact, the function of a large number of genes in mammalian embryogenesis is not yet investigated or not known. Transgenic and gene-targeted mouse lines have been used extensively to study the function of various genes in mammalian embryogenesis. These mouse knockout studies are relatively slow and this tool cannot keep pace with the rapid accumulation of new sequence information produced by the various genome projects. Therefore, what is needed is a technique that can be used to jump directly from sequence to function in a whole animal. For this, the post-transcriptional gene silencing (PTGS) by doublestranded RNA (dsRNA) or RNA interference (RNAi) has emerged as a new tool for studying gene function in an increasing number of organisms (Fire 1999) . Following its application in Caenorhabditis elegance (Fire et al. 1998) , the RNAi approach by introduction of dsRNA has been used in various mammalian species such as human (Brusselmans et al. 2005 , Cheng et al. 2005 , Hyslop et al. 2005 , mouse (Svoboda et al. 2000 , Wianny & ZernickaGoetz 2000 , Grabarek et al. 2002 , Stein et al. 2003 , Alizadeh et al. 2005 , Gui & Joyce 2005 , Plusa et al. 2005 ) and porcine (Cabot & Prather 2003) . Most recently, the work by our group (Nganvongpanit et al. 2006) and others (Paradis et al. 2005) have used the RNAi approach to suppress transcripts in bovine embryos and oocytes respectively. Recently, microinjection of dsRNA which interferes with genes that regulate cell polarity (Par3 and aPKC) in randomly selected blastomeres of cleavage-stage mouse embryos has enabled direction of defined cells to new positions and redirection of their fate in the preimplantation embryos (Plusa et al. 2005) .
During oocyte maturation, meiotic resumption is characterised by germinal vesicle breakdown (GVBD), chromosomal condensation, progression to metaphase of the first meiosis release of the first polar body and then arrest at the metaphase of the second meiosis (MII) (Motlik & Kubelka 1990) . The meiotic arrest (MII arrest) is maintained by the persistently high activity of cyclin B-p34 cdc2 kinase, also called maturation promotion factor (MPF) (Draetta & Beach 1988 , Brizuela et al. 1989 , Masui 1992 , Fan & Sun 2004 . MPF activity is necessary to maintain MII arrest in oocytes and the function of a multi-component complex, known as the cytostatic factor (CSF), which is required to sustain MPF activity (Hirao & Eppig 1997) . CSF activity is the coordinated function of at least two proteins, MAP kinase (MAPK) and mos. The activation of MAPK mediates the activation of MPF, a key regulator of the M phase, and results in the induction of GVBD in xenopus (Gotoh & Nishida 1995 , Kosako et al. 1996 , mouse (Araki et al. 1996) , bovine (Fissore et al. 1996) and porcine (Ohashi et al. 2003) . Mos, the C-mos protooncogene product, is one of the central regulators of meiosis in vertebrate oocytes (Sagata 1996) . Injection of mouse wild-type Mos RNA into bovine immature oocytes has induced a marked increase in the catalytic activity of MAPK and resulted in a considerable acceleration of GVBD, without affecting the ability of oocytes to progress to the MII stage (Fissore et al. 1996) .
However, so far, no clear evidence is available whether this kinase cascade in bovine is exclusively initiated by Mos or not. Inhibition of C-mos synthesis in mouse oocytes using RNAi has resulted in pathenogenetic activation (Wianny & Zernicka-Goetz 2000) , as has been observed in mos K/K knockout mouse. Oct-4 belongs to the sub-group of octamer-binding proteins that bind by the POU domain to the promoter and enhancer regions of various genes with octamer sites (Ovitt & Schö ler 1998) . The Oct-4 gene is presumed to be involved in the maintenance of an undifferentiated state and also the determination or establishment of the germ line (Ovitt & Schö ler 1998) . Moreover, Oct-4 influences several genes expressed during early development, including Fgf-4, Rex-1, Sox-2, OPN, hCG, Utf-1 (Pesce & Schö ler 2001) and INFt (Ezashi et al. 2001) . So far, the role and possible effect of C-mos and Oct-4 suppression in bovine oocytes and embryos have not yet been investigated. Therefore, here we investigated the effect of the suppression of C-mos and Oct-4 genes on the mRNA and protein expression during bovine embryogenesis. Moreover, biological effects of the suppression of these genes in oocytes and embryos will be assessed during in vitro development.
Materials and Methods

Synthesis of DNA template
Pairs of primers were designed according to bovine cDNA sequences found in GenBank (see Table 1 for details) using Primer Express Software v2.0 (Applied Biosystems, Foster City, CA, USA) to amplify C-mos and Oct-4 transcripts. These primers generated PCR amplicons corresponding to the coding sequence and the identity of the product was confirmed by sequencing. The first round of PCR amplification was performed using Taq DNA polymerase (Sigma). At first, the sample was heated at 95 8C for 5 min followed by 35 cycles of denaturing at 94 8C for 30 s, annealing at temperatures as indicated in Table 1 for 30 s and extension at 72 8C for 1 min. Following the last cycle, a 10-min elongation step at 72 8C was performed. The same PCR conditions have also been used for the second round of PCR amplification using a primer attached with T7 promoter (GTAATACGACTCACTATAGGG) to its 5 0 -end to generate two different templates for in vitro transcription to produce sense and antisense RNA strands (Table 1) . These C-mos and Oct-4 specific templates were purified using the QIAquick PCR Purification Kit (Qiagen).
Synthesis of dsRNA
The dsDNA templates coupled with T7 promoter were in vitro transcribed using RiboMAX Large Scale RNA Production T7 Systems (Promega) by which sense and antisense strands were transcribed from DNA template in separate reactions (Wianny & Zernicka-Goetz 2000) . After in vitro transcription, the DNA template was removed by digestion with RNase-free DNase at 37 8C for 15 min. Subsequently, the annealing of sense and antisense RNA strands was performed by incubating the reaction at 37 8C for 4 h after heating to 68 8C for 10 min to produce the dsRNA (Wianny & Zernicka-Goetz 2000) . Following a phenol/chloroform extraction, the RNA was precipitated with 0.1 volume of 3 M sodium acetate (pH 5.2) and 2.5 volume of 100% ethanol. After centrifugation at 15 000 rpm at 4 8C for 30 min, the resulting pellets were washed with 70% ethanol. Finally, the dsRNA pellets were resuspended in 10 ml diethylpyrocarbonate (DEPC)-treated water. The RNA concentration was measured by ultraviolet light absorbance using Ultraspec 2100 pro spectrophotometer (Amersham Biosciences). Both C-mos and Oct-4 dsRNA were diluted in DEPC-treated water to obtain a final concentration of 10 mg/ml and stored at K80 8C until used during microinjection of oocytes and zygotes. Two microlitres of the dsRNA and DNA template were resolved by electrophoresis on a 2% agarose gel to evaluate the size and purity of the dsRNA (Fig. 1) .
Oocyte recovery and in vitro maturation
Bovine ovaries were obtained from a local slaughterhouse and transported to the laboratory within 2-4 h after slaughter in a thermoflask containing a 0.9% saline solution supplemented with streptocombin. The cumulus oocyte complexes (COCs) were aspirated from follicles (2-8 mm in diameter) with an 18-gauge needle and COCs with multiple layers of cumulus cells were selected for in vitro maturation. The selected oocytes were washed in maturation medium (modified Parker medium, MPM) supplemented with 15% oestrus cow serum (OCS), 0.5 mM L-glutamine, 0.2 mM pyruvate, 50 mg/ml gentamycin sulphate and 10 ml/ml FSH (Folltropin, Vetrepharm, Canada) before being set into culture. The COCs were cultured in groups of 50 in 400 ml of maturation medium under mineral oil in four-well dishes (Nunc, Roskilde, Denmark). Maturation was performed for 24 h at 39 8C under a humidified atmosphere of 5% CO 2 in air.
In vitro fertilization of oocytes
After maturation, COCs were transferred into four-well dishes containing 400 ml of fertilization medium (Fert-TALP) supplemented with 2 mg/ml of heparin (Sigma), 0.2 mM pyruvate (Sigma) and 25 ml/ml penicillinamine, hypotaurine, adrenaline (epinephrine) (PHE). A swim-up procedure has been applied to obtain motile sperm cells from frozen-thawed semen (Parrish et al. 1988) . Briefly, frozen-thawed sperm cells were incubated in a tube containing 1.5 ml of sperm-TALP supplemented with 6 mg/ml BSA and 10 mM pyruvate for 50 min at 39 8C in a humidified incubator with 5% CO 2 . After this time, the supernatant was recovered and centrifuged at 250 g for 10 min at room temperature to recover motile sperm cells as a pellet. In vitro fertilization was performed using a final concentration of 2!10 6 sperm cells/ml in 400 ml fertilization drop containing a group of 50 COCs. Fertilization was initiated during co-incubation of spermatozoa and the matured oocytes for 20 h in the same incubator under the same temperature and atmospheric CO 2 content as used for maturation.
In vitro embryo culture
Following insemination, presumptive zygotes were stripped off from residual cumulus cells and attached spermatozoa by vortexing for 90 s in Charles Rosenkrans 1 (CR1) culture medium. After treatment, zygotes were washed once in fresh culture medium and cultured in groups of up to 50 zygotes in four-well dishes each containing 400 ml CR1 medium (Tesfaye et al. 2004 ) until day 8 after insemination. The CR1 medium is supplemented with 10% OCS, 20 ml/ml Eagle's basal medium (BME) (amino acids) and 10 ml/ml Minimum essential medium (MEM) (non-essential amino acids) (Gibco BRL).
Cleavage rate was assessed 48 h after insemination, while morula and blastocyst rate were determined at days 5 and 6-8 after insemination respectively. In vitro culture was also performed in a humidified atmosphere with 5% CO 2 at 39 8C.
Microinjection of dsRNA
In this study, two experiments were conducted to attain the objectives. In experiment 1, the effect of suppression of C-mos during oocyte maturation was assessed by microinjection of C-mos dsRNA at the immature oocyte stage. Oocytes used in this study were aspirated from cattle ovaries collected from a nearby slaughterhouse. Only good quality oocytes were selected for the experiment based on their morphological characteristics, mainly the intactness of the cumulus cells. Once the oocytes were selected, the cumulus cells were partially removed ( Fig. 2A ) by vortexing to avoid technical difficulties during microinjection of the dsRNA or water in the cytoplasm of the oocytes. Until used for microinjection, oocytes were held in tissue culture medium (TCM)-199 supplemented with 0.1% BSA (Sigma), 0.2 mM pyruvate and 50 mg/ml gentamycin sulphate (Sigma) in a humidified atmosphere with 5% CO 2 at 39 8C for 1-2 h. Prior to microinjection, immature oocytes were incubated for 20 min in TCM-199 supplemented with cytochalasin B at a final concentration of 8 mg/ml in order to reduce mechanical damage during injection (Paradis et al. 2005) . Subsequently, in three experimental replicates, a total of 935 immature oocytes were divided into three groups: C-mos dsRNA-injected (group 1, nZ327), water-injected group (group 2, nZ 303) and uninjected controls (group 3, nZ305). In experiment 2, the effect of suppression of embryonic Oct-4 gene using sequence-specific dsRNA on the mRNA expression and protein synthesis and in vitro development of embryos was also investigated after microinjection at the zygote stage. Zygotes were collected at 22-24 h post-fertilization from the fertilization medium and washed twice in CR1 medium before being used in the experiment. For this, a total of 1115 zygote-stage bovine embryos were produced as indicated above and categorized into three groups: those injected with Oct-4 dsRNA (group 1, nZ365), those injected with water (group 2, nZ375) and uninjected controls (group 3, nZ541).
In both experiments, microinjection was performed on an inverted microscope (Leica DM-IRB) at 200! Figure 2 Representative images of oocytes, whose cumulus cells are partially removed, before any treatment (A); some parthenogenetically developed oocytes after injection with C-mos dsRNA (B); those oocytes injected with water (C) and uninjected controls (D).
magnification. During microinjection a group of 50-60 immature oocytes or zygotes were placed in a 10 ml droplet of Hepes-buffered TCM 199 (H-TCM) under mineral oil and the dsRNA or water was placed in a 1 ml droplet near to the droplet containing the oocytes or zygotes. However, H-TCM medium was supplemented with cytochalasin B during the injection of immature oocytes to improve the survival rate of the oocytes after microinjection (Paradis et al. 2005) . Injection was performed by aspiration of the dsRNA (10 mg/ml) or water into the injection capillary (Cook, Ireland, K-MPIP-3335-5). The injection volume of w7 pl was estimated from the displacement of the meniscus of mineral oil in the capillary, which is 1 mm in diameter. The different treatment groups were injected one after the other, every time preparing a new dish with fresh medium. After microinjection, all groups of immature oocytes or zygotes were washed twice in CR1aa medium and set back into culture. Their survival rate was assessed 3-4 h after microinjection.
Oocytes and embryos collection
In order to assess the effect of sequence-specific dsRNA in oocytes and embryo on mRNA transcript abundance and protein expression, oocytes and embryos were collected at specific times after treatment for mRNA and protein analysis. In experiment 1, immature oocytes were cultured after microinjection with C-mos dsRNA or water until 48 hpi. While oocytes were cultured for 48 h after treatment to allow any parthenogenetic development, those used for transcriptional and protein expression analysis were collected at 24 h after microinjection and subsequent maturation. In experiment 2, zygotes injected with Oct-4 dsRNA or water and uninjected controls were cultured in vitro until day 8 blastocyst stage to assess development. The resulting blastocysts from each treatment group were used for both transcription and protein analysis.
Prior to freezing for mRNA or protein expression analysis, all oocytes/embryos were washed twice with PBS (Sigma) and treated with acidic Tyrode pH 2.5-3 (Sigma) to dissolve the zona pellucida. The zona-free oocytes and embryos were further washed twice in drops of PBS and frozen in cryo-tubes containing minimal amounts of lysis buffer (0.8% Igepal (Sigma), 40 U/ml RNasin (Promega), 5 mM dithiothreitol (DTT) (Promega)). Samples for Western blot analysis were additionally treated with protease inhibitor (Sigma). Until used for RNA isolation or Western blotting, all frozen embryos were stored at K80 8C.
RNA isolation and reverse transcription
A total of three pools each containing 20 matured oocytes or ten blastocyst stage embryos were used for mRNA isolation using oligo (dT) 26 attached magnetic beads (Dynal, Oslo, Norway) following the manufacturer's instruction. Briefly, oocytes or embryos in lysis buffer were mixed with 40 ml binding buffer (20 mM Tris-HCl with pH 7.5, 1 M LiCl, 2 mM EDTA with pH 8.0) and incubated at 70 8C for 5 min to obtain complete lysis of the embryo and release of RNA. Ten microlitres of oligo (dT) 25 magnetic bead suspension was added to the samples and incubated at room temperature for 30 min. The hybridised mRNA and oligo (dT) magnetic beads were washed three times with washing buffer (10 mM Tris-HCl with pH 7.5, 0.15 mM LiCl, 1 mM EDTA with pH 8.0). Finally, mRNA samples were eluted in 12 ml DEPC-treated water and reverse transcribed in 20 ml reaction volume containing 2.5 mM oligo (dT)12N (where NZG, A or C) primer, 4 ml of 5! first stand buffer (375 mM KCl, 15 mM MgCl 2 , 250 mM Tris-HCl pH 8.3), 2.5 mM of each dNTP, 10 U RNase inhibitor (Promega) and 100 U of SuperScript II reverse transcriptase (Invitrogen). In terms of the order of adding reaction components, mRNA and oligo (dT) primer were mixed first, heated to 70 8C for 3 min, and placed on ice until the addition of the remaining reaction components. The reaction was incubated at 42 8C for 90 min and terminated by heat inactivation at 70 8C for 15 min.
Real-time quantitative PCR
Quantification of C-mos, Oct-4 and Histone 2a (H2a) as endogenous control mRNA in the oocytes/embryos of each treatment group was assessed by real-time quantitative PCR. Furthermore, independent maternal transcript growth differentiation factor 9 (Gdf-9) has been quantified in the three treatment groups of experiment 1 to assess the specificity of mRNA suppression by the C-mos dsRNA. Similarly, the E-cadherin transcript has been quantified in the three treatment groups of experiment 2 to investigate the specificity of mRNA degradation by Oct-4 dsRNA. Moreover, the fibroblast growth factor (Fgf-4), which is reported to be coexpressed with Oct-4 gene (Nichols et al. 1998) , has been quantified in the treatment groups of experiment 2. The ABI Prism 7000 apparatus (Applied Biosystems) was used to perform the quantitative analysis using SYBR Green JumpStart Tag ReadyMix (Sigma) incorporation for dsDNA-specific fluorescent detection dye. Quantitative analyses of all studied transcripts were performed in comparison with H2a as an endogenous control (Robert et al. 2002) and were run in separate wells. The primer sequences were designed for PCR amplification according to the bovine cDNA sequences (Table 1) using Primer Express Software v2.0 (Applied Biosystems). Standard curves were generated for both target and endogenous control genes using serial dilution of plasmid DNA (10 1 -10 8 molecules). The PCRs were performed in 20 ml reaction volume containing 10 ml SYBR Green universal master mix (Sigma), optimal levels of forward and 
Western blot analysis
Groups of 120 matured oocytes and 50 embryos at day 7 blastocyst stage were used from each treatment group, which include C-mos or Oct-4 dsRNA-injected, waterinjected and uninjected control. In order to assess the amount of protein available before treatment in immature oocytes, equal amount of immature oocytes were also used for protein analysis prior to treatment. The proteins were extracted from the oocytes or embryos in loading buffer (26% of Tris 1 M pH 6.8, 12% SDS, 20% 2-mercaptoethanol and 40% glycerol). Following boiling for 5 min, proteins were separated on a 14% SDS-PAGE gel. Proteins were then transferred onto nitrocellulose transfer membrane, pore size 0.45 mm (Protran, Schleicher & Schuell BioScience, Dassel, Germany) using Trans-Blot SD; semi-dry transfer cell (BioRad). The membrane was stained with Ponceau S to evaluate the transfer quality and blocked for 1 h in Trisbuffered saline (20 mM Tris pH 7.5, 150 mM NaCl) containing 0.05% Tween-20 (TBS-T) and 1% polyvinylpyrrolidone (PVP) (Sigma). The membrane was then incubated at 4 8C overnight with the anti-rabbit C-mos primary antibody (Stressgen, Victoria, Canada) or Oct-3/4 (N-19) goat polyclonal primary antibody (Santa Cruz Biotechnology, Heidelberg, Germany). The primary antibody was diluted 1:500 in TBS-T containing 0.1% PVP prior to use. After incubation with the primary antibody, the membrane was washed six times for 10 min in TBS-T and the hybridization with the secondary antibody was performed at room temperature for 1 h. The horseradish-peroxidase (HRP) conjugated donkey anti-rabbit secondary antibody (Amersham Bioscience) and donkey anti-goat IgG-HRP secondary antibody (Santa Cruz Biotechnology) were used as secondary antibodies for C-mos and Oct-4 protein detection, respectively. Both secondary antibodies were diluted 1:50 000 in TBS-T containing 0.1% PVP. The membrane was finally washed six times for 10 min in TBS-T. The peroxidase activity was detected using the ECL Plus Western Blotting Detection System (Amersham Bioscience) following the manufacturer's instructions and visualized using Kodak BioMax XAR film (Kodak).
Differential cell staining of blastocysts
Differential staining of inner cell mass (ICM) and trophectoderm (TE) cells of bovine day 8 blastocysts from the three treatment groups was performed by incubating in freshly prepared permeabilising solution 1% Triton X-100 and 1 mg/ml propidium iodide in PBS containing 1 mg/ml BSA for 50 s. After washing twice in PBS-BSA medium, embryos were transferred into ethanol containing 0.03 mg/ml bisbenzimide (Hoechst 33258; Hoechst, Sigma), incubated for 4 min on an ice block and washed twice in PBS-BSA medium. Embryos were immediately mounted on glass slides and examined under fluorescence microscope to determine the number of ICM and TE cells.
Statistical analysis
The mRNA expression analysis for studied genes in all treatment groups was analysed based on the relative standard curve method. The relative expression data were analysed using the statistical analysis system (SAS) version 8.0 (SAS Institute Inc., Cary, NC, USA) software package. Differences in mean values between two or more experimental groups or developmental stages were tested using ANOVA followed by a multiple pair wise comparison using t-test. Differences of P!0.05 were considered to be significant.
Results
Experiment 1: effect of C-mos dsRNA on oocyte maturation, mRNA and protein expression
Effect of C-mos dsRNA on in vitro maturation of oocytes
The survival rate of the oocytes due to physical injury during microinjection was determined 3-4 h after microinjection. As indicated in Table 2 , no significant differences were observed in survival rate of immature oocytes injected with C-mos dsRNA and water (PO0.05). Compared to uninjected controls about 10% of injected oocytes did not survive the microinjection procedure. Sixty percent of oocytes injected with C-mos dsRNA showed extrusion of the first polar body after 24 h maturation, while only 50 and 44% of water injected and uninjected controls, respectively, showed first polar body extrusion as shown in Table 2 . Moreover, about 2.5% of the oocytes injected with C-mos dsRNA developed parthenogenetically to the two-cell stage, while no parthenogenetic development was observed in the water-injected group and uninjected controls (Fig. 2) .
Temporal expression pattern of maternal transcripts (C-mos and Gdf-9) and the effect of C-mos dsRNA on targeted mRNA
In order to get insight into the normal temporal expression pattern of the studied maternal transcripts (C-mos and Gdf-9), a real-time PCR analysis was conducted throughout the preimplantation developmental stages of in vitro produced bovine embryos (Fig. 3) . The C-mos and Gdf-9 were detected at higher level between immature oocyte and four-cell developmental stage and down-regulated or not detected in the later developmental stages. In order to assess the effect of C-mos dsRNA on the target mRNA, the relative expression level of this transcript was investigated between the treatment groups. Moreover, the selective suppression efficiency of C-mos dsRNA was assessed analysing the expression level of other maternal transcript (Gdf-9) between the same treatment groups. As shown in Fig. 4 , the relative expression level of C-mos transcript at the matured oocyte stage was found to be reduced by 70% compared to water injected and uninjected control group (P!0.01). However, no significant differences were observed in the relative abundance of this transcript between the water-injected group and uninjected controls. No differences were observed in the relative abundance of Gdf-9 transcript between the three treatment groups. This shows that neither the injection of water nor C-mos dsRNA affected the expression of Gdf-9 mRNA in the treated oocytes.
Effect of C-mos dsRNA on protein expression
To determine the effect of C-mos dsRNA on C-mos protein expression, Western blot analysis was performed using proteins extracted from matured oocytes of the three treatment groups. Moreover, protein extracted from oocytes at germinal vesicle (GV) stage and bovine muscle were used as positive control. As shown in Fig. 5 , there is a decrease in the intensity of C-mos protein band (39 kDa), while strong reactive bands were detected in the water-injected and uninjected control groups.
Experiment 2: effect of Oct-4 dsRNA on embryo development, mRNA and protein expression
Effect of Oct-4 dsRNA on in vitro development of bovine embryos
The survival rate of embryos after microinjection has been determined and no significant differences were observed between zygotes injected with dsRNA or water as shown in Table 3 . Compared to uninjected controls about 15% of embryos did not survive the microinjection procedure. The first cleavage rate after microinjection was 70, 80 and 81% for embryos injected with Oct-4 dsRNA and water and for uninjected controls respectively. However, these differences were not significant. Similarly, the day 5 morula rate was not significantly different between the three embryo groups, i.e. 38% in the Oct-4 dsRNA-injected, 40% in the water-injected Table 2 The phenotypes of embryo development following treatment with C-mos dsRNA and water compared to the uninjected controls.
Treatment group
No. of oocytes Survival rate at 3-4 h after treatment (%)
Polar body extrusion at 48 h after treatment (%)
Pathenogenetic developed oocytes at 48 h post-injection (%) and 41% in the uninjected control group (PO0.05).
There is a considerable variation in the number of blastocysts that appeared from each treatment group at each day of development between days 6 and 8 (Table 3) . Even though the overall blastocyst rate was lower in Oct-4 dsRNA-injected groups (35.8G1.5%) compared to the water-injected group (39.7G2.6%) and uninjected controls (41.6G4.15%), these differences are not significant (PO0.05).
Temporal expression profile of Oct-4 and Fgf-4 in bovine preimplantation stage embryos
The Oct-4 transcript was quantified throughout the preimplantation developmental stages of in vitro produced bovine embryos. This transcript was found to be highly abundant at early developmental stages (between immature oocytes and four-cell stages) and further down-regulated between eight-cell and morula stages. Relatively higher transcript abundance was also detected at the blastocyst stage. The Fgf-4 transcript was highly abundant only at morula and blastocyst stages but could not be detected in earlier developmental stages: from immature oocytes up to 16-cell stages (Fig. 6 ).
Effect of Oct-4 dsRNA on targeted mRNA and coexpressed genes
The results of mRNA transcript analysis in all treatment groups showed that Oct-4 mRNA was down-regulated by 72% in the Oct-4 dsRNA-injected group compared to the water-injected and uninjected control groups (P!0.01). In order to investigate the specificity of the Oct-4 dsRNA, E-cadherin gene was quantified in all treatment groups and no differences were subsequently found in the relative abundance of the E-cadherin subtranscript in all treatment groups. Moreover, the relative expression of Fgf-4 gene, which is known to be co-expressed with Oct-4, was found to be significantly down-regulated by 70% in the Oct-4 dsRNA-injected group compared to the other two groups as shown in Fig. 7 (P!0.01).
Effect of Oct-4 dsRNA on protein expression
To determine the effect of Oct-4 dsRNA on Oct-4 protein expression, Western blot analysis was performed using protein extracted from embryos at the blastocyst stage of the three treatment groups -those injected with Oct-4 dsRNA, those injected with water and those uninjected controls. Moreover, in vitro matured bovine oocytes before any treatment were used to assess Oct-4 protein produced from the maternal genome. Protein extracted from bovine brain was used as positive control. As shown in Fig. 8 , there is a decrease in the intensity of the Oct-4 protein reactive band (42 kDa), while strong reactive bands were detected in the water-injected and uninjected control groups.
Effect of Oct-4 down regulation in the number of ICM and TE cells of blastocysts
Differential cell staining of a representative number of blastocysts from the three treatment groups showed that the number of ICM cells was significantly lower in Oct-4 dsRNA-injected embryos (27.4G7.3) compared to the other two groups (Table 4) . However, no differences were observed in the number of TE cells between the three treatment groups. Consequently, the ratio of ICM:TE cells was lower (P!0.05) in Oct-4 dsRNA-injected groups than in the other two groups. The total cell number of blastocysts was consequently lower in the Oct-4 dsRNAinjected group (122.5G16.5) compared to the waterinjected group (134.3G6.8) and uninjected controls (140.2G18.4).
Discussion
Bovine preimplantation embryogenesis is supported by transcripts activated from both maternal and embryonic genome. Despite enormous advances in the identification and temporal expression profiling of bovine preimplantation genes, the specific function of the majority of transcripts is not yet known in bovine embryogenesis. Until recently, the function of a specific gene in bovine species has been predicted using knockout experiments conducted in mice (Larue et al. 1994 , Riethmacher et al. 1995 , which is an extremely long and laborious process in order to see any effects. To overcome this, the RNAi approach through introduction of sequence-specific dsRNA into the cells has been reported for various vertebrates and non-vertebrates as an effective tool to study gene function. Consequently, in the present study, we have demonstrated that the injection of sequence-specific dsRNA into the cytoplasm of bovine oocytes and zygotes induced suppression of maternal and embryonic transcript abundance, respectively, and resulted in subsequent decrease in protein synthesis and distinct phenotype. The microinjection procedure used to introduce the dsRNA in the present study is known to be advantageous over other techniques like electroporation (Grabarek et al. 2002) and transfection technique (Siddall et al. 2002) in controlling the amount of dsRNA to be introduced. In this method, physical injuries due to microinjection are inevitable. Consequently, in the present study, 10-15% of the oocytes and zygotes did not survive the microinjection procedure but this remains the same between the dsRNA-and waterinjected groups. Therefore, variation in developmental capacity due to the microinjection procedure has been ruled out. Previous studies have shown that the mechanism of RNAi is limited at the post-transcriptional level by degrading the sequence-specific mRNA or blocking the activity of ribosomal RNA (rRNA) (Svoboda 2004) , which leads to a loss of function in mice (Svoboda et al. 2000 , Wianny & Zernicka-Goetz 2000 , Grabarek et al. 2002 , Siddall et al. 2002 . Our results also showed that the injection of dsRNA of oocyte-or zygote-specific transcripts induced sequence-specific mRNA degradation and prevented subsequent protein synthesis during development of preimplantation embryos. In the studies conducted in mouse, C-mos is known to play a role as an essential component of CSF, which is responsible for arresting the maturing oocytes at metaphase in the second meiotic division (Wianny & Zernicka-Goetz 2000) . In this study, the injection of C-mos dsRNA at the immature oocyte stage resulted in 70% reduction in the amount of C-mos mRNA after maturation compared to the waterinjected group and uninjected controls. This result is comparable with the results reported in mouse oocytes, where a suppression of 80% of C-mos mRNA was achieved by microinjection of C-mos dsRNA (Svoboda et al. 2000) . Similar studies in mouse which targeted oocyte-specific maternal transcripts, namely Gdf-9 and Bmp-15, have shown the suppression of 89 and 78% in mRNA transcript abundance respectively (Gui & Joyce 2005) . Moreover, up to a level of 90% suppression in transcript abundance has been attained for Plat (Svoboda et al. 2000) , ITPRT (Xu et al. 2003) and BNC genes in mouse oocytes. A complete degradation of Cyclin B1 mRNA has been achieved in the work of Lazar et al. (2004) ) in rat oocytes treated with Cyclin B1 dsRNA. A recent report from our group (Nganvongpanit et al. 2006) , and also from others (Paradis et al. 2005) , have shown suppression of transcripts between 80 and 90% in bovine oocytes and embryos. The efficiency of targeted suppression of transcripts in mammalian oocytes or embryos seems to determine the extent of change in developmental phenotype. This variation in the efficiency of suppression of mRNA and protein synthesis and the expected developmental phenotype using dsRNA may be associated with the concentration of dsRNA introduced. This has been evidenced by Wianny & Zernicka-Goetz (2000) , who have shown that 50% of the oocytes injected with 2 mg/ml C-mos dsRNA showed spontaneous activation while only 36% of the oocytes injected with 0.1 mg/ml C-mos dsRNA developed parthenogenetically to cleavage-stage embryos. Studies in C-mos K/K knockout mouse have shown a reduced fertility because of the failure of mature eggs to arrest during meiosis (Colledge et al. 1994 ). The C-mos K/K oocytes undergo GVBD and extrusion of both polar bodies, followed in some cases by progression into cleavage. In the present study, despite significant reduction in the transcript abundance and protein synthesis, the proportion of oocytes undergoing spontaneous activation after treatment with C-mos dsRNA was much lower compared to the studies in mouse (Wianny & Zernicka-Goetz 2000) . In the present study, 60% of C-mos dsRNA-injected oocytes showed extrusion of the first polar body, of which 2.5% showed spontaneous activation and development to two-to fourcell stage. However, while only 44-50% of the oocytes showed first polar body extrusion in the water-injected group and uninjected controls, no spontaneous activation and parthenogenetic development has been observed in these treatment groups. The reason for the lower percentage of spontaneous activation in C-mos dsRNAinjected groups compared to comparable studies in the mouse cannot be explained at this level of the study.
The C-mos proto-oncogene is reported to be expressed at high levels in testes and ovaries, specifically in male and female germ cells (Kiessling & Cooper 1989) . Quantitative expression analysis of C-mos and GDF-9 throughout the preimplantation stage showed a pattern similar to most maternal transcripts. High-level accumulation of C-mos transcript after 24 h in vitro maturation (IVM) in fully grown oocytes in this study is consistent with previous studies in various species including mouse (Goldman et al. 1987 , Mutter & Wolgemuth 1987 and human oocytes (Pal et al. 1994) . Similarly, growth stage dependent analysis of Mos synthesis in bovine oocytes showed a higher level of Mos product in oocytes as they reached the MII stage (between 22 and 26 h of IVM) compared to low synthesis during the first 4 h of IVM and no synthesis in ageing MII-stage oocytes at 44-48 h IVM (Wu et al. 1997) . This expression pattern from our study and also from others may suggest the requirement of Mos expression during MII arrest and its possible role in MPF activity to maintain MII arrest. A significant level of C-mos and GDF-9 expression after fertilisation in this study may show the potential role of these transcripts in early stages of embryonic development. Our results have demonstrated that the injection of C-mos dsRNA leads to the specific degradation of the C-mos mRNA without affecting the expression of other genes (Gdf-9 and H2a). These results are consistent with the results obtained in mouse, where the injection of dsRNA directed towards C-mos mRNA resulted in the suppression of the targeted mRNA without affecting the untargeted transcript (Svoboda et al. 2000) . Previous reports in bovine oocytes also showed that the suppression of Cyclin B1 had no effect on the expression of housekeeping gene (b-actin) or Cyclin B2, as a member of the Cyclin B family (Paradis et al. 2005) . Moreover, our results have demonstrated that degradation of mRNA has resulted in a consequent reduction of protein synthesis as is evidenced by Western blot analysis.
Bovine embryogenesis in the early preimplantation stages is supported by mRNA and protein transcribed from maternal and embryonic genome. Until the major round of embryonic transcription during the 8-to 16-cell stage in bovine embryos, development is largely dependent on the transcripts and protein formed by the oocyte (Memili & First 2000) . Oct-4 is the earliest expressed transcription factor that is known to be crucial in murine preimplantation development (Okamoto et al. 1990 , Rosner et al. 1990 , Schö ler et al. 1990 . The mRNA and protein of Oct-4 have been found in murine oocytes and in the nuclei of subsequent cleavage stage embryos (Rosner et al. 1990 , Schö ler et al. 1990 , Palmieri et al. 1994 , while in the expanded murine blastocyst stage both mRNA and protein were predominantly found in the ICM (Palmieri et al. 1994 , Pesce et al. 1998 , Kirchof et al. 2000 . However, even in fully expanded bovine and porcine blastocysts, both ICM and trophectoderm cells were found to be positive for Oct-4 protein (Kirchof et al. 2000) . The quantitative expression profiling results throughout the preimplantation embryonic stages in the present study evidenced that Oct-4 is activated from both maternal and embryonic genome. Transcript abundance sharply increases after maturation (Fig. 8) . This shows that Oct-4 is activated from both maternal and embryonic genome during bovine embryogenesis. The detectable amount of Oct-4 transcript was very low between the eight-cell and morula stages, after which it is up-regulated at the blastocyst stage. Therefore, injection of Oct-4 dsRNA is targeting transcripts which are starting the minor embryonic activation at the two-to four-cell stages and in the major embryonic activation after the 16-cell stage. Consequently, injection of Oct-4 dsRNA at the zygote stage has resulted in a 72% reduction at the blastocyst stage compared with the uninjected controls. Despite slight variations in the relative abundance of Oct-4 transcript between the water-injected group and uninjected control group, differences are not significant. Similar studies in mouse have reported that suppression of about 90% has been achieved using sequence specific dsRNA ). Oct-4 as transcription factor protein is known to bind to DNA and activate or repress transcription of several genes expressed during early embryonic development (Shin et al. 2005) . In the present study, suppression of Oct-4 transcript in bovine embryogenesis using dsRNA has resulted in co-suppression of Fgf-4 gene at a level of 70%, while the transcript remained unaffected in the water-injected group and uninjected controls. This is in agreement with the observation made in Oct-4 K/K mouse embryos, where Fgf-4 transcript abundance has been reduced (Nichols et al. 1998) . Moreover, the expression of Fgf-4 transcript was found to be downregulated after targeted suppression of Oct-4 using siRNA expression vector in mouse (Haraguchi et al. 2004) . The Fgf-4 gene is an octamer-containing enhancer in its 3 0 noncoding region and has been demonstrated to respond to Oct-4 gene (Yuan et al. 1996 , Ambrosetti et al. 1997 , Daniels et al. 2000 . Studies in mouse have shown that this gene is coexpressed with Oct-4 in the ICM and epiblast (Ma et al. 1992 , Niswander & Martin 1992 . Recently, the effect of down-regulation of Oct-4 transcript using dsRNA on the expression of other genes in mouse embryos has been investigated using annealing control primer technique (Shin et al. 2005 ) whereby, of the ten genes, eight (Atp6ap2, GK003, Ddb1, hRscp, Dppa1, Dpp3, Sap18, and Rent1) were down-regulated and two (Rps14 and ETIF2B) were up-regulated in Oct-4 dsRNAinjected blastocysts. The specificity of Oct-4 dsRNA on targeted mRNA has been investigated by quantitative expression analysis of another blastocyst transcript (E-cadherin) and a house-keeping gene (H2a).
We have demonstrated that degradation of Oct-4 mRNA resulted in consequent reduction in protein synthesis and in developmental aberrations. Oct-4 dsRNA injection has affected the cleavage rate of zygotes to develop to the two-cell stage. Even though the day 5 morula rate was lower in the Oct-4 dsRNA-injected group compared to the water-injected group and uninjected controls, these differences were not significant. In order to investigate the effect of Oct-4 suppression on the rate of embryo development, we have investigated the blastocyst rate from day 6 to day 8. Most of the blastocysts from Oct-4 dsRNA-injected groups appeared at days 7 and 8 while only few blastocysts were found at day 6 of development. However, a comparable developmental rate with respect to blastocysts rate between day 6 and day 8 has been observed in the water-injected group and uninjected controls. The overall blastocyst rate was lower in Oct-4 dsRNA-injected embryos compared to the waterinjected group and uninjected controls but differences are not significant. While the Oct-4 K/K mouse showed a post-implantation lethality before egg cylinder formation, Oct-4-deficient mouse embryos developed normally up to blastocyst stage but the ICM were not pluripotent and divert to a trophoblast fate when placed in embryonic stem cell culture conditions (Nichols et al. 1998 ). Marked differences have been observed in Oct-4 mRNA and protein expression in murine and bovine species (Kirchof et al. 2000) . As opposed to the study in mouse where Oct-4 expression is correlated with the undifferentiated cell types, suggesting that Oct-4 is a marker for pluritency and its expression is restricted to ICM (Ovitt & Schö ler 1998) , the Oct-4 protein was detected in both ICM and trophectoderm cells of murine and bovine expanded blastocysts, indicating that it may be the biological activity of the Oct-4, and not simply its presence, that correlates with the embryonic stem cell type (Kirchof et al. 2000) .
In the present study, Oct-4 dsRNA-injected zygotes resulted in blastocysts of lower cell number compared to the water-injected group and uninjected controls. This was significantly evident in the number of ICM cells which were found to be reduced due to down-regulation of Oct-4 transcript. The optimal level of Oct-3/4 is reported to determine the fate of embryonic stem cells (Niwa et al. 2000) , in which less than a twofold increase from the normal expression level causes differentiation into ectoderm and mesoderm, whereas a lower level leads to dedifferentiation into trophectoderm. However, due to absence of differences in the number of TE cells between the three groups, migration of cells to TE cells cannot be evidenced in the present study.
In conclusion, the present study has evidenced the use of sequence specific C-mos and Oct-4 dsRNA to induce RNAi in bovine oocytes and embryos, respectively, to suppress maternal or embryonic transcripts leading to subsequent reduction in functional protein expression and result in a distinct developmental phenotype with respect to oocyte maturation, the rate of embryonic development and cell number of the resulting blastocysts.
